1887

Abstract

Fungal infections are a leading cause of morbidity and mortality in severely immunocompromised patients and have been increasing in incidence in recent years. Invasive aspergillosis (IA) is the most common filamentous fungal infection and is, in adults as well as in children, difficult to diagnose. Several PCR assays to detect DNA have been established, but so far, studies on molecular tools for the diagnosis of IA in children are few. We evaluated the results of a nested PCR assay to detect DNA in clinical samples from paediatric and adolescent patients with suspected IA. Blood and non-blood samples from immunocompromised paediatric and adolescent patients with suspected invasive fungal infection were sent for processing PCR to our laboratory. PCR results from consecutive patients from three university children's hospitals investigated between November 2000 and January 2007 were evaluated. Fungal infections were classified according to the EORTC classification on the grounds of clinical findings, microbiology and radio-imaging results. Two hundred and ninety-one samples from 71 patients were investigated for the presence of DNA by our previously described nested PCR assay. Two, 3 and 34 patients had proven, probable and possible IA, respectively. Sensitivity (calculated from proven and probable patients, =5) and specificity (calculated from patients without IA, =32) rates of the PCR assay were 80 and 81 %, respectively. Our nested PCR assay was able to detect DNA in blood, cerebrospinal fluid and bronchoalveolar lavage samples from paediatric and adolescent patients with IA with high sensitivity and specificity rates.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007393-0
2009-10-01
2019-11-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/10/1291.html?itemId=/content/journal/jmm/10.1099/jmm.0.007393-0&mimeType=html&fmt=ahah

References

  1. Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E. & other authors ( 2002; ). Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34, 7–14.[CrossRef]
    [Google Scholar]
  2. Baskova, L., Landlinger, C., Preuner, S. & Lion, T. ( 2007; ). The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J Med Microbiol 56, 1167–1173.[CrossRef]
    [Google Scholar]
  3. Bochennek, K., Abolmaali, N., Wittekindt, B., Schwabe, D., Klingebiel, T. & Lehrnbecher, T. ( 2006; ). Diagnostic approaches for immunocompromised paediatric patients with pulmonary infiltrates. Clin Microbiol Infect 12, 199–201.[CrossRef]
    [Google Scholar]
  4. Buchheidt, D., Baust, C., Skladny, H., Ritter, J., Suedhoff, T., Baldus, M., Seifarth, W., Leib-Moesch, C. & Hehlmann, R. ( 2001; ). Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 33, 428–435.[CrossRef]
    [Google Scholar]
  5. Buchheidt, D., Baust, C., Skladny, H., Baldus, M., Brauninger, S. & Hehlmann, R. ( 2002; ). Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol 116, 803–811.[CrossRef]
    [Google Scholar]
  6. Castagnola, E., Cesaro, S., Giacchino, M., Livadiotti, S., Tucci, F., Zanazzo, G., Caselli, D., Caviglia, I., Parodi, S. & other authors ( 2006; ). Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 25, 634–639.[CrossRef]
    [Google Scholar]
  7. Cesaro, S., Cecchetto, G., de Corti, F., Dodero, P., Giacchino, M., Caviglia, I., Fagioli, F., Livadiotti, S., Salin, F. & other authors ( 2007; ). Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutropenic patients. Pediatr Blood Cancer 49, 909–913.[CrossRef]
    [Google Scholar]
  8. Challier, S., Boyer, S., Abachin, E. & Berche, P. ( 2004; ). Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol 42, 844–846.[CrossRef]
    [Google Scholar]
  9. Chamilos, G., Luna, M., Lewis, R. E., Bodey, G. P., Chemaly, R., Tarrand, J. J., Safdar, A., Raad, I. I. & Kontoyiannis, D. P. ( 2006; ). Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 91, 986–989.
    [Google Scholar]
  10. Cunha, B. A. ( 2001; ). Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am 15, 567–590.[CrossRef]
    [Google Scholar]
  11. Denning, D. W. ( 1998; ). Invasive aspergillosis. Clin Infect Dis 26, 781–803.[CrossRef]
    [Google Scholar]
  12. El Mahallawy, H. A., Attia, I., Ali-el-Din, N. H., Salem, A. E. & Abo-el-Naga, S. ( 2002; ). A prospective study on fungal infection in children with cancer. J Med Microbiol 51, 601–605.
    [Google Scholar]
  13. El Mahallawy, H. A., Shaker, H. H., Ali, H. H., Mostafa, T. & Razak Abo-Sedah, A. ( 2006; ). Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med Mycol 44, 733–739.[CrossRef]
    [Google Scholar]
  14. Florent, M., Katsahian, S., Vekhoff, A., Levy, V., Rio, B., Marie, J. P., Bouvet, A. & Cornet, M. ( 2006; ). Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 193, 741–747.[CrossRef]
    [Google Scholar]
  15. Groll, A. H., Shah, P. M., Mentzel, C., Schneider, M., Just-Nuebling, G. & Huebner, K. ( 1996; ). Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33, 23–32.[CrossRef]
    [Google Scholar]
  16. Halliday, C., Hoile, R., Sorrell, T., James, G., Yadav, S., Shaw, P., Bleakley, M., Bradstock, K. & Chen, S. ( 2006; ). Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 132, 478–486.
    [Google Scholar]
  17. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P. & other authors ( 2002a; ). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408–415.[CrossRef]
    [Google Scholar]
  18. Herbrecht, R., Letscher-Bru, V., Oprea, C., Lioure, B., Waller, J., Campos, F., Villard, O., Liu, K. L., Natarajan-Ame, S. & other authors ( 2002b; ). Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20, 1898–1906.[CrossRef]
    [Google Scholar]
  19. Hope, W. W., Walsh, T. J. & Denning, D. W. ( 2005; ). Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5, 609–622.[CrossRef]
    [Google Scholar]
  20. Hovi, L., Saarinen-Pihkala, U. M., Vettenranta, K. & Saxen, H. ( 2000; ). Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 26, 999–1004.[CrossRef]
    [Google Scholar]
  21. Hovi, L., Saxen, H., Saarinen-Pihkala, U. M., Vettenranta, K., Meri, T. & Richardson, M. ( 2007; ). Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 48, 28–34.[CrossRef]
    [Google Scholar]
  22. Hummel, M. & Buchheidt, D. ( 2007; ). Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions? Mycoses 50 (Suppl. 1), 18–23.[CrossRef]
    [Google Scholar]
  23. Hummel, M., Baust, C., Kretschmar, M., Nichterlein, T., Schleiermacher, D., Spiess, B., Skladny, H., Morz, H., Hehlmann, R. & Buchheidt, D. ( 2004; ). Detection of Aspergillus DNA by a nested PCR assay is superior to blood culture in an experimental murine model of invasive aspergillosis. J Med Microbiol 53, 803–806.[CrossRef]
    [Google Scholar]
  24. Jordanides, N. E., Allan, E. K., McLintock, L. A., Copland, M., Devaney, M., Stewart, K., Parker, A. N., Johnson, P. R., Holyoake, T. L. & Jones, B. L. ( 2005; ). A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transplant 35, 389–395.[CrossRef]
    [Google Scholar]
  25. Kami, M., Fukui, T., Ogawa, S., Kazuyama, Y., Machida, U., Tanaka, Y., Kanda, Y., Kashima, T., Yamazaki, Y. & other authors ( 2001; ). Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33, 1504–1512.[CrossRef]
    [Google Scholar]
  26. Lass-Florl, C., Gunsilius, E., Gastl, G., Bonatti, H., Freund, M. C., Gschwendtner, A., Kropshofer, G., Dierich, M. P. & Petzer, A. ( 2004; ). Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 42, 4154–4157.[CrossRef]
    [Google Scholar]
  27. Lin, S. J., Schranz, J. & Teutsch, S. M. ( 2001; ). Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32, 358–366.[CrossRef]
    [Google Scholar]
  28. Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J. & Boogaerts, M. ( 2001; ). Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97, 1604–1610.[CrossRef]
    [Google Scholar]
  29. Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. ( 2002; ). Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34, 909–917.[CrossRef]
    [Google Scholar]
  30. McGinnis, M. R. ( 1983; ). Detection of fungi in cerebrospinal fluid. Am J Med 75, 129–138.
    [Google Scholar]
  31. Mennink-Kersten, M. A., Klont, R. R., Warris, A., Op den Camp, H. J. & Verweij, P. E. ( 2004; ). Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection. Lancet 363, 325–327.[CrossRef]
    [Google Scholar]
  32. Mennink-Kersten, M. A., Ruegebrink, D., Wasei, N., Melchers, W. J. & Verweij, P. E. ( 2006; ). In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-β-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44, 1711–1718.[CrossRef]
    [Google Scholar]
  33. O'Sullivan, C. E., Kasai, M., Francesconi, A., Petraitis, V., Petraitiene, R., Kelaher, A. M., Sarafandi, A. A. & Walsh, T. J. ( 2003; ). Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis. J Clin Microbiol 41, 5676–5682.[CrossRef]
    [Google Scholar]
  34. Pinel, C., Fricker-Hidalgo, H., Lebeau, B., Garban, F., Hamidfar, R., Ambroise-Thomas, P. & Grillot, R. ( 2003; ). Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 41, 2184–2186.[CrossRef]
    [Google Scholar]
  35. Roilides, E. ( 2006; ). Early diagnosis of invasive aspergillosis in infants and children. Med Mycol 44 (Suppl. 1), 199–205.
    [Google Scholar]
  36. Schabereiter-Gurtner, C., Selitsch, B., Rotter, M. L., Hirschl, A. M. & Willinger, B. ( 2007; ). Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 45, 906–914.[CrossRef]
    [Google Scholar]
  37. Siemann, M. & Koch-Dorfler, M. ( 2001; ). The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA). Mycoses 44, 266–272.
    [Google Scholar]
  38. Skladny, H., Buchheidt, D., Baust, C., Krieg-Schneider, F., Seifarth, W., Leib-Mosch, C. & Hehlmann, R. ( 1999; ). Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 37, 3865–3871.
    [Google Scholar]
  39. Steinbach, W. J. ( 2005a; ). New findings and unique aspects in pediatric aspergillosis. Med Mycol 43 (Suppl. 1), S261–S265.
    [Google Scholar]
  40. Steinbach, W. J. ( 2005b; ). Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J 24, 358–364.[CrossRef]
    [Google Scholar]
  41. Steinbach, W. J., Addison, R. M., McLaughlin, L., Gerrald, Q., Martin, P. L., Driscoll, T., Bentsen, C., Perfect, J. R. & Alexander, B. D. ( 2007; ). Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 26, 558–564.[CrossRef]
    [Google Scholar]
  42. Subira, M., Martino, R., Rovira, M., Vazquez, L., Serrano, D. & De La Cámara, R. ( 2003; ). Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 82, 80–82.
    [Google Scholar]
  43. Sulahian, A., Touratier, S. & Ribaud, P. ( 2003; ). False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349, 2366–2367.[CrossRef]
    [Google Scholar]
  44. Upton, A. & Marr, K. A. ( 2006; ). Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient. Curr Infect Dis Rep 8, 434–441.[CrossRef]
    [Google Scholar]
  45. Viscoli, C., Machetti, M., Cappellano, P., Bucci, B., Bruzzi, P., Van Lint, M. T. & Bacigalupo, A. ( 2004; ). False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 38, 913–916.[CrossRef]
    [Google Scholar]
  46. Walsh, T. J., Gonzalez, C., Lyman, C. A., Chanock, S. J. & Pizzo, P. A. ( 1996; ). Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 11, 187–290.
    [Google Scholar]
  47. Walsh, T. J., Shoham, S., Petraitiene, R., Sein, T., Schaufele, R., Kelaher, A., Murray, H., Mya-San, C., Bacher, J. & Petraitis, V. ( 2004a; ). Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 42, 4744–4748.[CrossRef]
    [Google Scholar]
  48. Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J. & other authors ( 2004b; ). Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351, 1391–1402.[CrossRef]
    [Google Scholar]
  49. White, P. L., Linton, C. J., Perry, M. D., Johnson, E. M. & Barnes, R. A. ( 2006; ). The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 42, 479–486.[CrossRef]
    [Google Scholar]
  50. Zaoutis, T. E., Heydon, K., Chu, J. H., Walsh, T. J. & Steinbach, W. J. ( 2006; ). Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 117, e711–e716.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007393-0
Loading
/content/journal/jmm/10.1099/jmm.0.007393-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error